Participant perceived understanding and perspectives toward pharmacogenomics: Mayo Clinic Right Drug, Right Dose, Right Time (RIGHT) Protocol

PURPOSE: To examine predictors of understanding preemptive CYP2D6 pharmacogenomic test results and to identify key features required to improve future educational efforts of preemptive pharmacogenomic testing. METHODS: 1010 participants were surveyed after receiving preemptive CYP2D6 pharmacogenomic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Genet Med
Main Authors: Olson, Janet E., Rohrer Vitek, Carolyn R., Bell, Elizabeth J., McGree, Michaela E., Jacobson, Debra J., St. Sauver, Jennifer L., Caraballo, Pedro J., Griffin, Joan M., Roger, Veronique L., Bielinski, Suzette J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5498279/
https://ncbi.nlm.nih.gov/pubmed/28055020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gim.2016.192
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados